Evidence-Based Medicine Guidelines
Dose-response characteristics of cholesterol-lowering drug therapies
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Dose-response Characteristics of Cholesterol-lowering Drug Therapies." Evidence-Based Medicine Guidelines, Duodecim Medical Publications Limited, 2019. Evidence Central, evidence.unboundmedicine.com/evidence/view/EBMG/456952/all/Dose_response_characteristics_of_cholesterol_lowering_drug_therapies.
Dose-response characteristics of cholesterol-lowering drug therapies. Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. https://evidence.unboundmedicine.com/evidence/view/EBMG/456952/all/Dose_response_characteristics_of_cholesterol_lowering_drug_therapies. Accessed April 24, 2024.
Dose-response characteristics of cholesterol-lowering drug therapies. (2019). In Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited. https://evidence.unboundmedicine.com/evidence/view/EBMG/456952/all/Dose_response_characteristics_of_cholesterol_lowering_drug_therapies
Dose-response Characteristics of Cholesterol-lowering Drug Therapies [Internet]. In: Evidence-Based Medicine Guidelines. Duodecim Medical Publications Limited; 2019. [cited 2024 April 24]. Available from: https://evidence.unboundmedicine.com/evidence/view/EBMG/456952/all/Dose_response_characteristics_of_cholesterol_lowering_drug_therapies.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Dose-response characteristics of cholesterol-lowering drug therapies
ID - 456952
BT - Evidence-Based Medicine Guidelines
UR - https://evidence.unboundmedicine.com/evidence/view/EBMG/456952/all/Dose_response_characteristics_of_cholesterol_lowering_drug_therapies
PB - Duodecim Medical Publications Limited
DB - Evidence Central
DP - Unbound Medicine
ER -
